Notice: Fall 2017 exams affected by natural disasters... More >

Expand/Collapse Close

ABIM knows that we have many physicians whose lives have been upended by recent natural disasters. If you live or work near an affected area, we understand that the weather may have impacted your ability to take your Fall 2017 exam as scheduled. We have developed a series of options to help you get through this process as smoothly as possible. If you have any questions, please call us at 1-800-441-ABIM (2246) or email request@abim.org.

American Board of Internal Medicine home page

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Endocrinology, Diabetes, & Metabolism Board

William F. Young Jr., MD, Chair

Dr. Young, a board certified internist and endocrinologist, is the Tyson Family Endocrinology Clinical Professor, and Chair of the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic in Rochester, Minnesota. He is a practicing endocrinologist with an active clinical practice and a dedicated teacher and mentor to residents and endocrinology fellows.

Currently, Dr. Young serves as a member of the American Board of Internal Medicine (ABIM) Council and the ABIM Endocrinology Board Exam Committee, and he serves as Chair of the ABIM Endocrinology, Diabetes, and Metabolism Board. Dr. Young is an internationally recognized endocrinologist who has served as past President of the Endocrine Society, past Chair of the Endocrine Society Self-Assessment Committee, an Associate Editor for the Journal of Clinical Endocrinology and Metabolism, and as a Senior Editor for Clinical Endocrinology. He is past Chair of the Endocrine Society's Annual Meeting Steering Committee and Nominating Committee. Dr. Young has published more than 240 articles on endocrine hypertension and adrenal and pituitary disorders. He has been the recipient of multiple education awards and has presented at over 300 national and international meetings and he has been an invited visiting professor for more than 100 medical institutions.

Dr. Young earned his medical degree at Michigan State University. He completed his internal medicine residency at William Beaumont Hospital and later completed fellowship training in endocrinology at Mayo Clinic.

As of May 2017, Dr. Young reported the following external relationships:

Funding for preclinical trial expenses and staff from the following company:

  • Nihon-Medi Physics, for animal studies to determine new approach to imaging the adrenal glands with PET-based technologies, receiving consulting fees.

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • Elsevier, receiving compensation for authorship for the book, The Netter Collection of Medical Illustrations: Endocrine System.
  • Wiley-Blackwell, receiving compensation for authorship.

Dr. Young serves in a significant role with the following organizations, receiving reimbursement or compensation as listed:

  • International Society of Endocrinology, serving as an Executive Board Member, without compensation.

Ashok Balasubramanyam, MD

Dr. Balasubramanyam, a board certified internist and endocrinologist, is Professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism at Baylor College of Medicine, and Chief, Endocrine Service, Ben Taub General Hospital, Houston. Texas. His academic career has involved basic and translational research, education (as Director of the Endocrine Fellowship Program and of Baylor's Clinical Scientist Training Program) and clinical service.

Currently, Dr. Balasubramanyam serves as a member of the Endocrinology, Disease, and Metabolism Board of the American Board of Internal Medicine, and as a member of the Hormone Health Network Committee of the Endocrine Society. He has served as President of the Association of Program Directors in Endocrinology and Metabolism.

Dr. Balasubramanyam earned his undergraduate degree at Yale University and his medical degree at St. John's Medical College, Bangalore, India. He completed residency training and was Chief Resident at Baylor College of Medicine, and he completed fellowship training in endocrinology at Massachusetts General Hospital, Boston.

As of January 2017, Dr. Balasubramanyam reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed below:

  • UpToDate, receiving compensation for authorship.

Gary Bloom

Mr. Bloom, a thyroid cancer survivor, is co-founder and Executive Director of ThyCa: Thyroid Cancer Survivors’ Association, Inc., where he directs the overall organization, including: operational, technological, and financial management, and maintains collaborations with numerous professional, patient, and community organizations. He works closely with the ThyCa Volunteer Board of Directors and committee coordinators. He leads committee development and directs fundraising. He also develops the program for the Annual International Thyroid Cancer Survivors' Conference and recruits all professional speakers. He is a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board.

Previously, Mr. Bloom served as an Applications Engineer for Eclipsys Corporation where he designed and implemented workflow streamlining applications for large health care organizations. He also developed custom and standard reports, and prepared teaching materials and trained clients in the use of Eclipsys’ database structure and reporting system.

Mr. Bloom also served as Controller and Director of Operations at Intelus where he was responsible for all financial, human resources, and administrative responsibilities. He was responsible for all financial activity and financial reporting to management, venture capital investors, and the Board of Directors. Additionally, he secured and managed employee benefits, facility space requirements, office insurance and security.

Mr. Bloom received a B.S. in Accounting from the University of Vermont.

As of July 2017, Mr. Bloom reported the following external relationships:

Mr. Bloom serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • ThyCa: Thyroid Cancer Survivors' Association, Inc., Executive Director, receiving compensation and reimbursement for travel expenses.

Marjorie Ewertz, RN, BSN

Ms. Ewertz is on the Faculty of the Johns Hopkins University School of Medicine, Division of Endocrinology, Diabetes and Metabolism. She served as the Director of Clinical Operations for four years, until 2016, working closely with physicians, nurses and fellows. She is a member of the Fellows Advisory Committees. A proponent of the electronic medical records, Ms. Ewertz took the lead implementing EPIC for the Division of Endocrinology.

Ms. Ewertz has been involved in education, research and patient care for Johns Hopkins Medicine since 1994 as an endocrine nurse. Previously, Ms. Ewertz served as Adjunct Faculty of the Johns Hopkins University School of Nursing. She was also on the faculty of the St. Joseph Hospital and Union Memorial Hospital Schools of Nursing, teaching Medical Surgical Nursing and Critical Care.

Ms. Ewertz serves as a member of the American Board of Internal Medicine for Endocrinology, Diabetes, and Metabolism Board. She was the first nurse accepted for membership to the American Thyroid Association in 2003 and has been on the Clinical Affairs Committee. She was a member of the Endocrine Society and served on the Hormone Foundation Committee. Ms. Ewertz has served the Endocrine Nurses Society as President and Chairman of the Program and Development Committees since 1994.

Ms. Ewertz received her bachelor's degree in nursing from the University of Maryland School of Nursing.

As of January 2017, Ms. Ewertz reported no external relationships.

Paul W. Ladenson, MD

Dr. Ladenson, a board certified internist and endocrinologist, is the John Eager Howard Professor of Endocrinology and Metabolism and Director of the Division of Endocrinology, Diabetes, & Metabolism at the Johns Hopkins Medical Institutions, where he is Professor of Medicine, Pathology, Oncology, and Radiology and Radiological Sciences, as well as a University Distinguished Professor. He is also Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. His academic career has been as a clinical investigator and educator in thyroidology, and his principal research interests have been thyroid hormone actions on the heart, thyroid cancer, thyroid hormone analogs and health economic analyses related to clinical endocrinology.

Dr. Ladenson serves as a member of the American Board of Internal Medicine (ABIM) Endocrinology, Diabetes, and Metabolism Board as well as the ABIM Endocrinology, Diabetes, and Metabolism Board Exam Committee. He is past Editor-in-Chief of the Journal of Clinical Endocrinology & Metabolism, and has served in the past as President of the Association of Program Directors in Endocrinology and Metabolism, the Association of Subspecialty Professors and the American Thyroid Association.

Dr. Ladenson graduated summa cum laude from Dartmouth College with a degree in English literature, from Oxford University with a degree in physiology, and from Harvard Medical School. He trained as a resident in internal medicine and as a clinical and research fellow in endocrinology at Massachusetts General Hospital.

As of January 2017, Dr. Ladenson reported the following external relationships:

Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:

  • Veracyte, providing advice regarding clinical and health-economic research related to molecular genetic testing for differential diagnosis of thyroid nodules, receiving compensation for travel expenses and honoraria.
  • Viking Therapeutics, providing advice regarding preclinical and clinical research related to applications of thyromimetic compounds to metabolic disorders, receiving honoraria.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, receiving honoraria:

  • Sentier Therapeutics, for providing advice regarding preclinical and clinical research related to compounds for thyroid hormone therapy.
  • Veracyte, receiving support for lectures to regional professional societies.

Jonathan D. Leffert, MD

Dr. Leffert is a board certified clinical endocrinologist, and Managing Partner of North Texas Endocrine Center in Dallas, Texas. He has been in private single specialty group or solo practice for the last 25 years, where his passion for excellent patient care drives him daily in his clinical and organizational activities.

Dr. Leffert has been active in organizational medicine since 2000, serving on the board of his county medical society, state medical society Political Action Committee, and now as President of the American Association of Clinical Endocrinologists (AACE). In addition, he is currently the Delegate to the American Medical Association (AMA) for AACE. At the AMA House of Delegates Meeting in 2013, Dr. Leffert led a coalition that resulted in the designation of obesity as a disease. He is also a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board.

Dr. Leffert received a degree in biology from Brown University and his medical degree from the University of Minnesota.

He completed his internship and residency in internal medicine at UT Southwestern/Parkland Memorial Hospital. Dr. Leffert began his research fellowship by studying genes that regulate carbohydrate metabolism in the Touchstone Diabetes Center and completed his clinical fellowship in endocrinology, diabetes and metabolism at UT Southwestern Medical Center in Dallas.

As of January 2017, Dr. Leffert reported the following external relationships:

Funding for clinical trial expenses and staff, paid to North Texas Endocrine Center, from the following companies:

  • AbbVie, for a study of atrasentan on type 2 diabetes with nephropathy.
  • Boehringer Ingelheim, for a study of empagliflozin added to insulin for subjects with type 1 diabetes.
  • Mylan, for a study of glargine injections on type 1 diabetes.
  • Novo Nordisk, for multiple type 1 and type 2 diabetes trials with new insulin analogs.
  • Sanofi, for multiple trials involving type 2 diabetes with insulin glargine injections and type 1 or type 2 diabetes with hypercholesterolemia.

Dr. Leffert serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Association of Clinical Endocrinologists, President, without compensation.

Susan J. Mandel, MD, MPH

Dr. Mandel, a board certified endocrinologist, is Professor of Medicine and Radiology at the Perelman School of Medicine at the University of Pennsylvania, where she also directs the Endocrine Fellowship Program. She serves as the Associate Chief of the Division of Endocrinology, Diabetes, and Metabolism at the Hospital of the University of Pennsylvania, where she directs the Thyroid Cancer Program and the Thyroid Nodule Clinic. Her research interests include the use of sonography in the evaluation of patients with thyroid nodules and as surveillance for those with thyroid cancer and thyroid disease during pregnancy. She has been invited to lecture throughout the United States and internationally on these topics.

Currently, Dr. Mandel is a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board. She is also a member of The Endocrine Society, where she currently holds the position of Vice President Physician in Practice; the American Association of Clinical Endocrinologists; and the American Thyroid Association. She is a past President of the Association of Program Directors in Endocrinology, Diabetes, and Metabolism. Dr. Mandel has served on the writing groups for both the American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer and The Endocrine Society Guideline for the Management of Thyroid Disease during Pregnancy. She directs the Introductory and Advanced Ultrasound Workshops for The Endocrine Society.

Dr. Mandel has won prestigious awards for her education and clinical research accomplishments, including the 2011 Endocrine Society's Laureate Distinguished Educator Award, the 2012 H. Jack Baskin Educator Award of the American Association of Clinical Endocrinologists, and the George Murray Lectureship Award from the British Thyroid Association. She has authored articles in the New England Journal of Medicine, the Annals of Internal Medicine, and JAMA, as well as articles in endocrine and radiology journals.

After graduating from Harvard College, she received her medical degree from the College of Physicians and Surgeons, Columbia University, where she also completed her internal medicine residency. She received her fellowship training in endocrinology at the Brigham and Women's Hospital.

As of January 2017, Dr. Mandel reported no external relationships.

Cacia V. Soares-Welch, MD

Dr. Soares-Welch is a practicing board certified endocrinologist at the Northeast Georgia Diagnostic Clinic in Gainesville, Georgia. Her professional career has centered on providing endocrine care to the population of northeast Georgia and surrounding states since 2005. She serves as a Clinical Assistant Professor at the Medical College of Georgia/University of Georgia Medical Partnership Campus and at the Medical College of Georgia.

Dr. Soares-Welch is the immediate past President of the Georgia Chapter of the American Association of Clinical Endocrinologists (GA-AACE). She also served in this position in 2010 to 2011, and was a member of the GA-AACE Board of Directors in 2009 to 2010. Dr. Soares-Welch is currently a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board. Additionally, she has served as a member of the Board of Directors and as the Liaison for Associate Physicians at the Northeast Georgia Diagnostic Clinic, LLC. She was a member of the Credentials Committee at the Northeast Georgia Medical Center in 2009 to 2010, and is currently involved in the development of the review and revision of clinical privileges for the endocrinology specialty there.

Dr. Soares-Welch earned her medical degree from the University of South Carolina School of Medicine in Columbia, South Carolina. She completed her internal medicine residency and endocrinology fellowship at the Mayo School of Graduate Medical Education in Rochester, Minnesota.

As of January 2017, Dr. Soares-Welch reported the following external relationships:

Dr. Soares-Welch serves in significant role with the following organization, receiving reimbursement or compensation as listed:

  • American Association of Clinical Endocrinologists, immediate past President for the Georgia Chapter, without compensation.